PFIZER TO ACQUIRE BLOOD DISORDER DRUGMAKER GLOBAL BLOOD THERAPEUTICS FOR $5.4B
Pfizer Inc. (NYSE:PFE) is reported to have signed an agreement to buy Global Blood Therapeutics Inc (NASDAQ:GBT) in a deal of $5.4 billion. The acquisition to the blood disorder drug…